期刊文献+

CCN5过表达对肝星状细胞α-SMA、Collagen Ⅰ表达的影响及其机制 被引量:3

Effects of CCN5 overexpression on the expression of α-SMA and Collagen Ⅰ in hepatic stellate cells and its mechanism
下载PDF
导出
摘要 目的:研究结缔组织生长因子-5(CCN5)与肝星状细胞活化的关系及其作用机制。方法:以人肝星状细胞系LX-2为研究对象,以转化生长因子-β1(TGF-β1)刺激LX-2细胞,Western blot测定CCN5及CCN2表达变化;构建CCN5过表达载体,转染人肝星状细胞LX-2,使CCN5在LX-2中过表达;采用RT-PCR及Western blot测定α-平滑肌肌动蛋白(α-SMA)与Ⅰ型胶原表达变化情况;为进一步研究其作用机制,采用RT-PCR及Western blot对Smad2表达及Smad2磷酸化水平进行测定。结果:正常情况下,LX-2细胞中CCN2表达量远高于CCN5,TGF-β1刺激后CCN2明显增高,而CCN5无变化;与正常对照组和空载体组相比,转染组CCN5在LX-2中成功过表达后,α-SMA及Ⅰ型胶原表达量显著下降(P<0.01);Smad2磷酸化水平显著下降(P<0.01)。结论:CCN5具有抑制肝星状细胞活化的作用,与CCN家族另一重要分子CCN2的促纤维化作用截然相反,为肝纤维化的防治提供新的思路。 Objective: To investigate the relationship between connective tissue growth factor (CCNS) and hepatic stellate cell (HSC) activation as well as the mechanism of action. Methods: As the research object, LX-2 cells were stimulated with transforming growth factor-β1 (TGF-β1 ), and the protein expression levels of CCN5 and CCN2 were determined by Western blot; Hepatocyte high expression system of CCN5 was constructed and transfected hepatic stellate cells (HSC) to make CCN5 overexpression; The expression levels of α-smooth muscle actin (α-SMA) and collagen I were determined by RT-PCR and Western blot. To further study its mechanism of action, Smad2 and phosphorylation level of Smad2 were determined by RT-PCR and Western blot. Results: Under normal circumstances, CCN2 expression levels were much higher than CCN5 in LX-2 cells, while CCN2 expression was significantly higher than CCN5 if LX-2 cells were stimulated by TGF-β1. However, there was no change for CCNS. Compared with the control group and the vector group, CCN5 was successfully overexpressed in the transfection group, and mRNA and protein levels of α-SMA and collagen Ⅰ were significantly decreased (P 〈 0.01). Meanwhile, phosphorylafion level of Smad2 was also significantly decreased ( P 〈 0.01 ). Conclusion: CCNS, which has the function that inhibits HSC activation, has the oppositerole compared with CCN2, therefore, a new idea was proposed for the prevention and treatment of liver fibrosis.
出处 《中国应用生理学杂志》 CAS CSCD 2013年第5期411-415,共5页 Chinese Journal of Applied Physiology
关键词 CCN5 肝星状细胞 肝纤维化 CCN5 hepatic stellate cell hepatic fibrosis
  • 相关文献

参考文献10

  • 1Yoon PO, Lee MA, Cha H, et al. The opposing effects of CCN2 and CCN5 on the development of cardiac hypertrophy and fibrosis[J]. JMol Cell Cardiol, 2010, 49(2): 294-3(13.
  • 2Livak K J, Schmittgen TD. Analysis of relative gene expres- sion data using real-time quantitative PCR and the 2 (-Delta Delta C(T)) Method[J]. Methods, 2001, 25(4): 402--408.
  • 3Reeves HL, Friedman SL. Activation of hepatic stellate cells- a key issue in liver fibrosis[J]. Front Biosci, 2002, 7(4) : 808-826.
  • 4Brenner DA. Molecular pathogenesis of liver fibrosis [ J ].Tram Am Clin Climatol Assoc, 2009, 120: 361-368.
  • 5Iredale JP, Thompson A, Henderson NC. Extracelldar ma- trix degradation in liver fibrosis: Biochemistry and regulation [j]. Biochim Biophys Acta, 2013, 1832(7) : 876-883.
  • 6Yue J, Mulder KM. Transforming growth factor-beta signal transduction in epithelial cells[J]. Pharmacol Ther, 2001, 91(1): 1-34.
  • 7Hemandez-Gea V, Friedman SL. Pathogenesis of liver fibro- sis[J]. Annu Rev Pathol, 2011, 6: 425-456.
  • 8Borkham- Kamphorst E, van Roeyen CR, Van de Leur E, et a/. CCN3/NOV small interfering RNA enhances fibrogenic gene expression in primary hepatic stellate cells and cirrhotic fat storing cell line CFSC[J]. J Cell Corrmu Signal, 2012, 6(1): 11-25.
  • 9郝军,刘淑霞,韦金英,要红叶,段惠军.高脂喂养大鼠肾小管上皮细胞SREBP-1、TGF-β1、α-SMA的表达和细胞外基质沉积[J].中国应用生理学杂志,2010,26(3):307-311. 被引量:4
  • 10陈烁苹,郑景晨,倪连松,陈国荣,周雷.血管紧张素-(1-7)对糖尿病大鼠肾脏PDGF、TGF-β的影响[J].中国应用生理学杂志,2008,24(4):475-478. 被引量:6

二级参考文献17

  • 1Bethesda M D. US Renal Date System: USRDS 2003 Annnual Date Report:Atlas of End-Stage Renal Disease in the United States[R]. National Institute of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2003.
  • 2van Esch J H M, Tom B, Dive V, et al. Selective Angiotensin-converting Enzyme C-Domin Inhibition is sufficient to prevent angiontensin I-induced Vasoconstriction [ J ]. Hypertension, 2005, 45 : 120- 125.
  • 3Ueda. S, Masumori-Maemoto S, Wada A, et al. Angiotensin-( 1-7 ) potentiates bradykinin-induced vasodilation in man [J]. Hypertension, 2001,19 ( 11 ) : 2001-2009.
  • 4Yokota T, Ma R C, Park J Y, et al. Role of protein kinase C on the expression of platelet-derived growth factor and endothelin-1 in the retina of diabetic rats and cultured retinal capillary pericytes[J ]. Diabetes, 2003, 52(3) : 838-845.
  • 5Reeves W B, Andreoli T E. Transforming growth factor-β contributes to progressive diabetic nephropathy [ J ]. Proc Natl Acad Sci U S A, 2000,97 (14) : 7667- 7669.
  • 6Clark M A, Diz D I, Tallant E A. Angiotensin-(1-7) Downregulates the Angiotensin Ⅱ Type 1 Receptor in Vascular Smooth Muscle Cells [ J ]. Hypertension,2001,37(4): 1141-1146.
  • 7Freeman E J, Chisolm G M, Ferrario C M, et al. Angiotensin(1-7) inhibits vascular smooth muscle cell growth[J]. Hypertension, 1996,28(1): 104-108.
  • 8Strawn W B, Ferrario C M, Tallant E A, et aI. Angiotensin-(1-7) reduces smooth muscle growth after vascular injury [ J ]. Hypertension 1999, 33 ( 1Pt2 ) : 207-211.
  • 9Zak A, Tvrzicka E, Vecka M, et al. Severity of metabolic syndrome unfavorably influences oxidative stress and fatty acid metabolism in men [J]. Tohoku J Exp Med, 2007, 212(4) 359-371.
  • 10Jiang T, Wang Z, Proctor G, et al. Diet-induced obesity in C57BL/6J mice causes increased renal lipid accumulation and glomerulosclerosis via a sterol regulatory element-binding protein-lc-dependent pathway [J]. J Biol Chem, 2005, 280 (37) : 32317-32325.

共引文献8

同被引文献35

引证文献3

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部